The Efficacy and Safety of Herbal Medicine Treatment for Obese Patients With Spinal and Joint Pain

Inclusion Criteria: * Patients aged 19 years or older but under 70 years. * Individuals with a BMI of 25 kg/m² or higher, meeting the Asia-Pacific obesity criteria. * Individuals experiencing spinal or joint pain, with the most severe pain rated as NRS 5 or higher. * Individuals who voluntarily agree to participate in the clinical trial and sign the consent form. Exclusion Criteria: * Presence of findings on X-ray examination of the pain site, such as acute fractures or dislocations, requiring surgical intervention. * Diagnosis of specific diseases that may cause secondary obesity (e.g., Cushing's syndrome, hypothyroidism, insulinoma, adult growth hormone deficiency, etc.). * Current use of medications related to obesity treatment or a history of taking such medications within the past month. * Presence of other chronic diseases that may interfere with treatment efficacy or interpretation of results, such as stroke, myocardial infarction, kidney disease, active hepatitis, diabetic neuropathy, dementia, epilepsy, etc. * Current use of steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study outcomes. * Unsuitability or safety concerns for herbal medicine treatment: individuals with conditions or post-surgical complications affecting drug absorption or digestion, severe liver disease, or kidney disease. * Pregnant or planning to become pregnant, or currently breastfeeding. * Participation in other clinical trials, except for observational studies without therapeutic intervention. * Difficulty in providing informed consent. * Other cases where the investigator deems participation in the clinical study inappropriate.